Evidence map›Paper›PMID 22198778›Full record

GuidelineEndoscopy2012

Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED).

M Dinis-Ribeiro, M Areia, A C de Vries, R Marcos-Pinto, M Monteiro-Soares, A O'Connor, C Pereira, P Pimentel-Nunes, R Correia, A Ensari and 18 more

3 registry-linked trialsOpen access · bronzeAbstract readPractice Guideline
PubMed Full text at PMC Publisher
In one paragraph

Guideline in Endoscopy, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 275 papers, 13 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
275citing papers in PubMed, 13 pooled it
39.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02197351 naunknown statusnot on this mapstarted 2014, after this paper: background citation

Prospective Controlled Trial of Narrow Band Imaging for Detection of Gastric Cancer Precursors

TypeinterventionalSponsorUniversity of Southern CaliforniaRan2014 to 2023Enrolled220ConditionsGastric Cancer, Gastric Metaplasia, Gastric DysplasiaArmsWhite light biopsy, Protocolled, Narrow Band Imaging Guided Biopsy
NCT03250091 recruitingnot on this mapstarted 2017, after this paper: background citation

Surveillance Strategies of Patients With Precancerous Conditions and Lesions in the Stomach

TypeobservationalSponsorUniversity of LatviaRan2017 to 2027Enrolled2,000ConditionsGastric Cancer, Gastric Intestinal Metaplasia, Gastric Atrophy, Gastric DysplasiaArmsUpper endoscopy with biopsies, Plasma/serum sampling, Biopsies for gastric microbiota, Faecal sample acquisition
NCT04522752 unknown statusnot on this mapstarted 2020, after this paper: background citation

Long-term Endoscopic Follow-up of Benign Epithelial Gastric Polyps: a Multicenter Prospective Large Sample Cohort Study

TypeobservationalSponsorFirst Affiliated Hospital Xi'an Jiaotong UniversityRan2020 to 2023Enrolled200ConditionsBenign Gastric PolypArmsSize and pathological type of benign epithelial gastric polyp
3 · Its place in the literature

Who cites it

275 citing papers in PubMed, 13 syntheses or guidelines pooled it, 677 citations in OpenAlex.

  1. Pooled it
  2. First regional consensus on the management ofWorld journal of gastroenterology · 2025
    Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Guideline
  9. Pooled it
  10. Guideline
  11. Pooled it
  12. The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2018
    Pooled it
  13. Pooled it
  14. Pathologic Validation of Endoscopic Ablative Therapy for Gastric Epithelial Neoplasia: A Randomized Controlled Trial.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2021
    Trial
  15. Trial
  16. Prevalence and Progression of Subtypes of Gastric Premalignant Lesions: A Systematic Review and Meta-Analysis.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2026
    Review
  17. Article
  18. Review
  19. Article
  20. Article

215 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 16 institutions in 11 countries.

M Dinis-RibeiroDepartment of Gastroenterology, Portuguese Oncology Institute of Coimbra, Portugal. mdinisribeiro@gmail.com
M Areia
A C de Vries
R Marcos-Pinto
M Monteiro-Soares
A O'Connor
C Pereira
P Pimentel-Nunes
R Correia
A Ensari
J M Dumonceau
J C Machado
G Macedo
P Malfertheiner
T Matysiak-Budnik
F Megraud
K Miki
C O'Morain
R M Peek
T Ponchon
A Ristimaki
B Rembacken
F Carneiro
E J Kuipers
European Society of Gastrointestinal Endoscopy
European Helicobacter Study Group
European Society of Pathology
Sociedade Portuguesa de Endoscopia Digestiva
Instituto Português de Oncologia Francisco Gentil · PTUniversidade do Porto · PTCentre for Health Technology and Services Research · PTErasmus MC · NLTallaght University Hospital · IEAnkara University · TRCentre Hospitalier Universitaire de Nantes · FRHôpital Beau-Séjour · CHHôpital Edouard Herriot · FRHospital de São João · PTJapanese Foundation For Cancer Research · JPLeeds General Infirmary · GBOtto-von-Guericke-Universität Magdeburg · DEUniversité de Bordeaux · FRUniversity of Helsinki · FIVanderbilt University · US

Funding

Role of Iron and B-Catenin Activation in Gastric CarcinogenesisP01CA116087 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2009 to 2026
$27.5M
H.Pylori Relationship to Digestive Diseases and CancerR01CA077955 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2003 to 2026
$9.7M
Helicobacter Pylori and Gastrointestinal BiologyR01DK058587 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PEEK, RICHARD M. · 2001 to 2024
$7.8M
NCI NIH HHS P01 CA116087NCI NIH HHS R01 CA077955NIDDK NIH HHS R01 DK058587
6 · The paper itself

Abstract

Atrophic gastritis, intestinal metaplasia, and epithelial dysplasia of the stomach are common and are associated with an increased risk for gastric cancer. In the absence of guidelines, there is wide disparity in the management of patients with these premalignant conditions. The European Society of Gastrointestinal Endoscopy (ESGE), the European Helicobacter Study Group (EHSG), the European Society of Pathology (ESP) and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) have therefore combined efforts to develop evidence-based guidelines on the management of patients with precancerous conditions and lesions of the stomach (termed MAPS). A multidisciplinary group of 63 experts from 24 countries developed these recommendations by means of repeat online voting and a meeting in June 2011 in Porto, Portugal. The recommendations emphasize the increased cancer risk in patients with gastric atrophy and metaplasia, and the need for adequate staging in the case of high grade dysplasia, and they focus on treatment and surveillance indications and methods.

Indexed as

BiopsyEvidence-Based MedicineGastric MucosaGastritis, AtrophicGastroscopyHelicobacter InfectionsHelicobacter pyloriHumansMetaplasiaPepsinogensPopulation SurveillancePrecancerous ConditionsStomach NeoplasmsPepsinogens

Identifiers

PMID22198778
PMCPMC3367502
OpenAlexW2011487761

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.